Marijuana compounds could be linked to a possible cure for prostate cancer.
Thursday, August 20th, 2009 Posted in prostate cancer | No Comments »A research team at the University of Alcala in Madrid found that chemicals in cannabis stopped the growth of prostate cancer cells in laboratory tests. Researchers believe the cannabinoids -- methanandamide and JWH-015 – work against prostate cancer by blocking a ...
Aptocine used in two Phase 3 clinical trials as treatment for prostate cancer.
Wednesday, August 19th, 2009 Posted in prostate cancer | No Comments »Light Sciences Oncology, Inc. (LSO) announced that Aptocaine, a water-soluble drug targeted inside a tumor or other tissue by a small, single-use, disposable drug activator included with the drug, is used in two Phase 3 clinical trials for solid tumors ...
Smoking is a risk factor for prostate cancer
Tuesday, August 18th, 2009 Posted in prostate cancer risks | No Comments »A research team at University of South Carolina School of Medicine has evaluated the relationship between smoking and adenocarcinoma of the prostate. Observational cohort studies show an association of smoking with prostate cancer incidence and mortality. Ill-defined exposure categories in many ...
Importance of PSA Testing in high-risk men
Monday, August 17th, 2009 Posted in prostate cancer diagnosis | No Comments »The National Comprehensive Cancer Network (NCCN) recently updated the NCCN Guidelines for Prostate Cancer Early Detection incorporating the results of the recent ERSPC trial that assessed the benefit of PSA screening. It is important to note that the NCCN Guidelines for ...
Prostate cancer recurrence and obesity
Sunday, August 16th, 2009 Posted in prostate cancer risks | No Comments »After a review of data from the Shared Equal Access Regional Cancer Hospital (SEARCH) prostate cancer database, a research team has suggested that obese men with prostate cancer - regardless of race - are at particularly high risk for recurrence ...
Neoadjuvant hormone therapy unjustified prior to surgery
Saturday, August 15th, 2009 Posted in hormone therapy, prostatectomy | No Comments »For a variety of reasons, hormone therapy appeared to have effects on the structure of the prostate which could, in many cases, make the surgical procedure more difficult to execute. A research team at Memorial Sloan-Kettering Cancer Center, NY, USA, investigated ...
How patient understand of the risks and benefits of active surveillance
Friday, August 14th, 2009 Posted in watchful waiting | No Comments »A research team from Erasmus Medical Center, Rotterdam, the Netherlands, has investigated the levels of knowledge of prostate cancer and the perception of active surveillance (AS) in men on AS, as AS for early prostate cancer instead of radical treatment ...
Potential benefit of prostate cancer screening overestimated by European men
Thursday, August 13th, 2009 Posted in prostate cancer diagnosis | No Comments »An European scietific team carried out a careful and detailed study in 9 European countries in an attempt to obtain accurate, country-specific information on public knowledge of the benefits of screeningfor breast and prostate cancers. Their study demonstrated that: 89 percent ...
Oral sodium clodronate ups survival in advanced prostate cancer
Wednesday, August 12th, 2009 Posted in prostate cancer | No Comments »British researchers say oral sodium clodronate improves overall survival in advanced prostate cancer patients but doesn't reduce the risk of death in those with localized disease, The findings are believed to be the first to show an overall survival benefit conferred ...
Monoclonal antibody denosumab promising against prostate cancer
Tuesday, August 11th, 2009 Posted in prostate cancer | No Comments »Amgen Inc. researchers report that new bone-building drug has worked well in a trial of men whose bones were weakened by the hormone therapy they were taking for prostate cancer. Twice-yearly treatment with denosumab, a new targeted therapy to stop bone ...